tirzepatide hypertension Learn about GLP-1 Learn about Wegovy and Zepbound (tirzepatide) Learn what these meds can do not just for weight loss but also for diabetes / cholesterol / / fatty liver Users of Zepbound or Mounjaro

Repeatedly injecting the same location causes tissue thickening that can reduce semaglutide efficacy and cause discomfort

Mar 23, 2026 Your retatrutide is losing potency right now

Never adjust the dose without medical guidance

Further studies are needed to assess the potential cardiovascular and renal benefits of combination therapy and to determine suitable patient population for the therapy

Novo Nordisk on Friday released headline data from the Phase III REDEFINE 1 trial of its next-generation weight-loss therapy CagriSema, touting superior weight loss in people with obesity and overweight than just cagrilintide, semaglutide (marketed as Wegovy for weight loss and Ozempic for diabetes) or placebo